Get the Stockscreener App
1.94
2.02%
-0.04
After Hours:
1.91
-0.03
-1.55%
Jaguar Health Inc stock is traded at $1.94, with a volume of 31,247.
It is down -2.02% in the last 24 hours and down -16.74% over the past month.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
See More
Previous Close:
$1.98
Open:
$1.96
24h Volume:
31,247
Relative Volume:
0.23
Market Cap:
$4.22M
Revenue:
$10.48M
Net Income/Loss:
$-37.74M
P/E Ratio:
-0.1199
EPS:
-16.1846
Net Cash Flow:
$-29.03M
1W Performance:
-7.62%
1M Performance:
-16.74%
6M Performance:
-84.15%
1Y Performance:
-92.61%
1-Day Range:
$1.90
$1.96
1-Week Range:
$1.90
$2.13
52-Week Range:
$1.5701
$33.25
Jaguar Health Inc Stock (JAGX) Company Profile
Name
Jaguar Health Inc
Sector
Industry
Phone
415-371-8300
Address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Compare JAGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
1.94 | 7.34M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
Jaguar Health Inc Stock (JAGX) Latest News
How to use Fibonacci retracement on Jaguar Health Inc.Watch List & Free Expert Verified Stock Movement Alerts - newser.com
News impact scoring models applied to Jaguar Health Inc.Market Sentiment Report & Daily Momentum Trading Reports - newser.com
Has Jaguar Health Inc. formed a bullish divergenceMarket Sentiment Summary & Technical Entry and Exit Tips - newser.com
How dovish Fed policy supports Jaguar Health Inc. (1JA0) stockJuly 2025 Setups & High Conviction Investment Ideas - newser.com
How hedge fund analytics apply to Jaguar Health Inc. stockWeekly Profit Report & Daily Growth Stock Investment Tips - newser.com
Will Jaguar Health Inc. benefit from macro trendsMarket Sentiment Report & Community Trade Idea Sharing Platform - newser.com
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts - Shelby Star
FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease - Lubbock Avalanche-Journal
Can Jaguar Health Inc. stock surprise with earnings upsideQuarterly Trade Summary & Weekly Sector Rotation Insights - newser.com
Is Jaguar Health Inc. stock attractive for passive investorsPortfolio Value Summary & Weekly High Momentum Picks - newser.com
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Providence Journal
Will Jaguar Health Inc. stock pay special dividendsRate Cut & Low Risk Growth Stock Ideas - newser.com
Published on: 2025-10-28 08:23:49 - fcp.pa.gov.br
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders - Corpus Christi Caller-Times
What analysts say about Jaguar Health Inc 1JA0 stockSector-Based Investing & Amplify Gains With Picks - earlytimes.in
Jaguar Health Inc Stock (JAGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):